Capricor Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, CAPR, Capricor Therapeutics Inc, priceseries

Capricor Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
4.54
Close
4.49
High
4.75
Low
4.42
Previous Close
4.58
Daily Price Gain
-0.09
YTD High
4.81
YTD High Date
Feb 17, 2022
YTD Low
2.56
YTD Low Date
Jan 24, 2022
YTD Price Change
1.31
YTD Gain
41.19%
52 Week High
6.22
52 Week High Date
Jun 22, 2021
52 Week Low
2.56
52 Week Low Date
Jan 24, 2022
52 Week Price Change
-0.66
52 Week Gain
-12.82%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 13. 2017
28.20
Feb 23. 2017
29.62
7 Trading Days
5.02%
Link
LONG
Jul 18. 2017
13.60
Jul 19. 2017
14.45
1 Trading Days
6.25%
Link
LONG
Sep 18. 2017
13.20
Oct 9. 2017
25.31
15 Trading Days
91.71%
Link
LONG
Nov 10. 2017
24.70
Nov 15. 2017
26.50
3 Trading Days
7.29%
Link
LONG
Feb 2. 2018
19.10
Feb 5. 2018
20.80
1 Trading Days
8.90%
Link
LONG
Oct 29. 2018
8.07
Nov 12. 2018
9.63
10 Trading Days
19.31%
Link
LONG
Jan 4. 2019
5.10
Jan 23. 2019
5.87
12 Trading Days
14.99%
Link
LONG
Mar 13. 2019
4.71
Mar 26. 2019
5.20
9 Trading Days
10.41%
Link
LONG
Mar 17. 2020
1.17
Mar 18. 2020
1.31
1 Trading Days
11.97%
Link
LONG
Mar 23. 2020
1.16
Mar 26. 2020
1.38
3 Trading Days
18.53%
Link
LONG
Apr 17. 2020
1.57
May 13. 2020
6.85
18 Trading Days
336.08%
Link
LONG
Jul 17. 2020
5.32
Jul 30. 2020
7.16
9 Trading Days
34.62%
Link
LONG
Sep 17. 2020
5.89
Sep 18. 2020
6.23
1 Trading Days
5.77%
Link
LONG
Sep 22. 2020
5.31
Sep 23. 2020
5.68
1 Trading Days
6.97%
Link
LONG
Jan 7. 2021
3.98
Jan 27. 2021
5.75
13 Trading Days
44.36%
Link
LONG
Jan 28. 2022
3.15
Feb 14. 2022
4.07
11 Trading Days
29.32%
Link
Company Information
Stock Symbol
CAPR
Exchange
NasdaqCM
Company URL
http://www.capricor.com
Company Phone
(310) 358-3200
CEO
Linda Marbán
Headquarters
California
Business Address
8840 WILSHIRE BLVD, 2ND FLOOR, BEVERLY HILLS, CA 90211
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001133869
About

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on November 20, 2013 and is headquartered in Beverly Hills, CA.

Description

Capricor Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company's development stage drug candidates for cardiovascular diseases include CAP-1002 that is in Phase II clinical trials; and CAP-2003, which is in pre-clinical development for the treatment of certain cardiac and inflammatory conditions. The company was founded in 2005 and is headquartered in Beverly Hills, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading